Lung Neuroendocrine Tumor
2 clinical trials · Condition
◉ Watch Lung Neuroendocrine Tumor
| Record | Firm | Date |
|---|---|---|
| Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors (NCT03375320) | National Cancer Institute (NCI) | 2018-10-26 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
Track Lung Neuroendocrine Tumor automatically
Every clearance here is in the API, with alerts when new ones post.